Thrive Therapies, a US-based pediatric healthcare company providing school-based therapy and behavioral health services, announced on October 22, 2026, that it had raised $7.7 million in funding. The round was led by LiveOak Ventures, with participation from Activate Venture Partners and Charter School Growth Fund.
Founded in 2023 and led by founder and CEO Dr. Kristin McGraner, Thrive Therapies delivers healthcare services to children with disabilities within school environments. Its services include speech-language therapy, occupational therapy, physical therapy, psychological evaluations, and behavioral healthcare.
The company combines in-school clinical services with technology designed to help educational institutions manage student care, track progress, and administer Medicaid reimbursements. Its Thrive Clinical platform integrates clinical documentation, data analysis, and outcomes reporting to support healthcare delivery and administrative processes.
Thrive Therapies serves more than 200 schools and districts across six US states: Florida, North Carolina, Ohio, Tennessee, Texas, and Washington. According to the company’s funding announcement, Thrive Clinical had documented more than 18,000 therapy sessions.
The company plans to use the new funding to enter additional markets, expand its clinical workforce, and continue developing Thrive Clinical. These investments are intended to support its school-based healthcare operations and technology platform as it extends services to additional educational institutions.

